Antibodies used were from Cell Signaling (Danvers, MA, USA) against DYRK1A, P107, P16, p-RB, RB, p-CycD1, CycD1, CycB1, p-CDK1, Ki67, GAPDH, anti-rabbit HRP-linked, anti-mouse HRP-linked; from Abcam (Cambridge, UK) against CDK1, p-CDK1, CDC23, LIN52; and from Santa Cruz Biotechnology (Dallas, TX, USA) against LIN37, DYRK1A, LIN9, P130.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.